2-(2,3-dichlorophenyl)-3,7-dihydroxy-8-(pyrrolidin-1-ylmethyl)-4H-chromen-4-one

ID: ALA4874187

PubChem CID: 164627580

Max Phase: Preclinical

Molecular Formula: C20H17Cl2NO4

Molecular Weight: 406.27

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1c(O)c(-c2cccc(Cl)c2Cl)oc2c(CN3CCCC3)c(O)ccc12

Standard InChI:  InChI=1S/C20H17Cl2NO4/c21-14-5-3-4-11(16(14)22)20-18(26)17(25)12-6-7-15(24)13(19(12)27-20)10-23-8-1-2-9-23/h3-7,24,26H,1-2,8-10H2

Standard InChI Key:  DKMZIRVPLSULTK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   20.7503  -23.3725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7491  -24.1920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4572  -24.6010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4554  -22.9636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0425  -22.9640    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.4530  -22.1464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7440  -21.7399    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.1640  -23.3689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1629  -24.1895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8691  -24.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5809  -24.1915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5821  -23.3709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8714  -22.9573    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.8668  -25.4157    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.2875  -24.6021    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.2889  -22.9669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9960  -23.3789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7042  -22.9727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7066  -22.1547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9949  -21.7445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2896  -22.1531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5817  -21.7447    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   24.9940  -20.9273    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   20.6543  -20.9284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8544  -20.7609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4479  -21.4698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9966  -22.0754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  9  2  0
  8  4  2  0
  4  1  1  0
  1  5  1  0
  4  6  1  0
  6  7  1  0
  8  9  1  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 10 14  2  0
 11 15  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 12 16  1  0
 21 22  1  0
 20 23  1  0
  7 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27  7  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4874187

    ---

Associated Targets(Human)

RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 406.27Molecular Weight (Monoisotopic): 405.0535AlogP: 4.77#Rotatable Bonds: 3
Polar Surface Area: 73.91Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 5.16CX Basic pKa: 8.05CX LogP: 2.63CX LogD: 2.59
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -0.11

References

1. Hou Y, Kuang W, Min W, Liu Z, Zhang F, Yuan K, Wang X, Sun C, Cheng H, Wang L, Xiao Y, Pu S, Xin GZ, Yang P..  (2021)  Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment.,  64  (20.0): [PMID:34644502] [10.1021/acs.jmedchem.1c00087]

Source